Abiopharma

🔍 Liuzza Nicholas Reyland JR (Director)

Company: Beeline Holdings, Inc. (BLNE)

Report Date: 2025-09-15

Detailed Transactions and Holdings:

• Sold 11,750 shares of Common Stock (Direct)
  Date: 2025-09-15 | Code: G | equity_swap_involved: 0 | shares_owned_after: 235,466.00 | transaction_form_type: 4 | Footnotes: F1, F4
• Sold 12,343 shares of Common Stock (Direct)
  Date: 2025-09-19 | Code: G | equity_swap_involved: 0 | shares_owned_after: 247,809.00 | transaction_form_type: 4 | Footnotes: F2, F4
• Sold 9,000 shares of Common Stock (Direct)
  Date: 2025-09-23 | Code: G | equity_swap_involved: 0 | shares_owned_after: 256,809.00 | transaction_form_type: 4 | Footnotes: F3, F4
• Holds 0 shares of Common Stock (Direct)
  Date: 2025-09-15 | Code: H | shares_owned_after: 4,113,155.00

Footnotes:

• F1: Represents a bona fide gift of 11,750 shares of common stock of Beeline Holdings, Inc. (the "Issuer") made by the reporting person to his son.
• F2: Represents a bona fide gift of 12,343 shares of the Issuer's common stock made by the reporting person to his son.
• F3: Represents a bona fide gift of 9,000 shares of the Issuer's common stock made by the reporting person to his son.
• F4: Represents (i) shares held by a trust of which the reporting person is trustee and (ii) shares held by members of the reporting person's immediate family which are deemed to be indirectly beneficially owned by the reporting person following the gifts as reported herein. See footnotes (1) through (3).